<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03609710</url>
  </required_header>
  <id_info>
    <org_study_id>PSTLAR</org_study_id>
    <nct_id>NCT03609710</nct_id>
  </id_info>
  <brief_title>Application of Left Colic Artery Preservation, Anastomotic Reinforcing Sutures and Transanal Tube in Robotic Low Anterior Resection</brief_title>
  <official_title>The Effect of Combined Application of Left Colic Artery Preservation, Anastomotic Reinforcing Sutures and Transanal Tube Placement in Robotic Low Anterior Resection for Rectal Cancer to Prevent Anastomic Leak：A Prospective, Single-center, Randomized Control Trial Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the results of combined application of left colic
      artery preservation, anastomotic reinforcing sutures and postoperative transanal tube
      placement in robotic Low Anterior Resection for Rectal Cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Combined application of left colic artery preservation, anastomotic reinforcing sutures and
      postoperative transanal tube placement in robotic low anterior resection for rectal cancer
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomotic leak rate</measure>
    <time_frame>30 days post operatively</time_frame>
    <description>Anastomotic leak is a common and serious complication after low anterior, resection, and often leads to re-operation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reoperation rate after anastomotic leak</measure>
    <time_frame>30 days post operatively</time_frame>
    <description>Anastomotic leak is a common and serious complication after low anterior, resection, and often leads to excrement peritonitis, and re-operation as colostomy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>PSTLAR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined application of left colic artery preservation, anastomotic reinforcing sutures and postoperative transanal tube placement in robotic low anterior resection for rectal cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NORLAR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional robotic low anterior resection for rectal cancer without left colic artery preservation, anastomotic reinforcing sutures or postoperative transanal tube placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transanal tube placement</intervention_name>
    <description>Transanual tube placement after anastomosis in low anterior resection for rectal cancer.</description>
    <arm_group_label>PSTLAR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left colic artery preservation</intervention_name>
    <description>Left colic artery preservation during operation for lower rectal cancer</description>
    <arm_group_label>PSTLAR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Anastomotic reinforcing sutures</intervention_name>
    <description>Anastomotic reinforcing sutures during operation for lower rectal cancer</description>
    <arm_group_label>PSTLAR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robotic surgery</intervention_name>
    <description>Robotic low anterior resection for rectal cancer</description>
    <arm_group_label>NORLAR</arm_group_label>
    <arm_group_label>PSTLAR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of low rectal cancer; Low rectal cancer was defined by the presence
             of the inferior pole of the tumor below the peritoneal reflection (in 11 cm from the
             anal margin)

          -  Primary tumor has undergone histologically comfirmed rectal adenocarcinoma

          -  Together with clinical or radiological evidence of Stage II (T3-4, N0, M0) or Stage
             III (T1-4, N1-2, M0) disease (according to the 2016 revision of the International
             Union Against Cancer primary tumor, regional nodes, metastasis (TNM) staging system)

          -  Performance status (ECOG) 0~1

          -  Adequate hematological function: Neutrophils≥1.5 x109/l and platelet count≥100 x109/l;
             hemoglobin (Hb) ≥9g/dl (within 1 week prior to randomization)

          -  Adequate hepatic and renal function: Serum bilirubin≤1.5 x upper limit of normal
             (ULN), alkaline phosphatase ≤5x ULN, and serum transaminase (either primary tumor,
             regional nodes, metastasis (AST) or ALT) ≤ 5 x ULN(within 1 week prior to
             randomization);

          -  Written informed consent for participation in the trial.

        Exclusion Criteria:

          -  Body mass index (BMI) more than 30 kg/m2

          -  Serious pre-operative comorbidity, including cardiovascular disease (coronary
             arteriosclerosis, arrhythmia, heart failure), pulmonary dysfunction (lung emphysema,
             obstructive lung disease), liver insufficiency (Child-Pugh B or C), renal
             insufficiency (serum creatinine &gt;2.0 mg/dl), and arterial circulation disturbance
             (occlusion of arterial vessels of limb in patient's history

          -  History of accepting abdominal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Jianmin Xu</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianmin Xu, MD</last_name>
      <phone>+8613501984869</phone>
      <email>xujmin@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Wenju Chang, MD</last_name>
      <phone>+8613764476150</phone>
      <email>chang_erich@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>July 23, 2018</study_first_submitted>
  <study_first_submitted_qc>July 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <last_update_submitted>August 2, 2018</last_update_submitted>
  <last_update_submitted_qc>August 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Xu jianmin</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Low rectal cancer</keyword>
  <keyword>Robotic surgery</keyword>
  <keyword>Anastomotic leak</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

